NCT06643000 2025-03-06
Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis
Henan Cancer Hospital
Phase NA Recruiting
Clinical Trials
6 trialsNCT04973293 2024-11-19
Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
Ruijin Hospital
Phase NA Recruiting
NCT05407155 2022-06-07
BETTER
Fudan University
Phase NA Unknown
NCT04944069 2021-06-29
ATTRACT
Second Affiliated Hospital of Nanchang University
Phase NA Unknown
NCT01063283 2019-11-18
AVF4759
University of Chicago
Phase NA Completed
NCT00675597 2015-11-20
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Phase NA Completed